Quarterly report · Q2
7915.TEDINET S100OVBF
Period2022-01-01 → 2022-06-30
Filed2022-08-10
StandardIFRS
ConsolidatedYes
Data checks12 of 12 passed
Key figures · 52
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Operating income | ¥6.3bn | 2022-01-01 → 2022-06-30 | Cons. | Operating profit loss IFRS |
| Operating income | ¥3.8bn | 2022-04-01 → 2022-06-30d | Cons. | Operating profit loss IFRS |
| Operating income | ¥10.9bn | 2021-01-01 → 2021-06-30 | Cons. | Operating profit loss IFRS |
| Operating income | ¥5.5bn | 2021-04-01 → 2021-06-30d | Cons. | Operating profit loss IFRS |
| Profit before tax | ¥9.5bn | 2022-01-01 → 2022-06-30 | Cons. | Profit loss before tax IFRS |
| Profit before tax | ¥6.0bn | 2022-04-01 → 2022-06-30d | Cons. | Profit loss before tax IFRS |
| Profit before tax | ¥19.5bn | 2021-01-01 → 2021-12-31 | Cons. | Profit loss before tax IFRS (5-year summary) |
| Profit before tax | ¥12.2bn | 2021-01-01 → 2021-06-30 | Cons. | Profit loss before tax IFRS |
| Profit before tax | ¥6.0bn | 2021-04-01 → 2021-06-30d | Cons. | Profit loss before tax IFRS |
| Net income (owners) | ¥7.9bn | 2022-01-01 → 2022-06-30 | Cons. | Profit loss attributable to owners of parent IFRS |
| Net income (owners) | ¥4.6bn | 2022-04-01 → 2022-06-30d | Cons. | Profit loss attributable to owners of parent IFRS |
| Net income (owners) | ¥15.9bn | 2021-01-01 → 2021-12-31 | Cons. | Profit loss attributable to owners of parent IFRS (5-year summary) |
| Net income (owners) | ¥10.6bn | 2021-01-01 → 2021-06-30 | Cons. | Profit loss attributable to owners of parent IFRS |
| Net income (owners) | ¥5.2bn | 2021-04-01 → 2021-06-30d | Cons. | Profit loss attributable to owners of parent IFRS |
| Net income | ¥7.9bn | 2022-01-01 → 2022-06-30 | Cons. | Profit loss IFRS |
| Net income | ¥4.6bn | 2022-04-01 → 2022-06-30d | Cons. | Profit loss IFRS |
| Net income | ¥10.6bn | 2021-01-01 → 2021-06-30 | Cons. | Profit loss IFRS |
| Net income | ¥5.2bn | 2021-04-01 → 2021-06-30d | Cons. | Profit loss IFRS |
| Total assets | ¥228.6bn | at 2022-06-30 | Cons. | Assets IFRS |
| Total assets | ¥209.3bn | at 2021-12-31 | Cons. | Assets IFRS |
| Total assets | ¥207.6bn | at 2021-06-30 | Cons. | Total assets IFRS (5-year summary) |
| Total liabilities | ¥116.7bn | at 2022-06-30 | Cons. | Liabilities IFRS |
| Total liabilities | ¥111.0bn | at 2021-12-31 | Cons. | Liabilities IFRS |
| Net assets / equity | ¥111.8bn | at 2022-06-30 | Cons. | Equity IFRS |
| Net assets / equity | ¥98.3bn | at 2021-12-31 | Cons. | Equity IFRS |
| Net assets / equity | ¥94.1bn | at 2021-06-30 | Cons. | Equity IFRS |
| Net assets / equity | ¥81.9bn | at 2020-12-31d | Cons. | Equity IFRS |
| Equity (owners) | ¥111.9bn | at 2022-06-30 | Cons. | Equity attributable to owners of parent IFRS |
| Equity (owners) | ¥98.3bn | at 2021-12-31 | Cons. | Equity attributable to owners of parent IFRS |
| Equity (owners) | ¥94.1bn | at 2021-06-30 | Cons. | Equity attributable to owners of parent IFRS (5-year summary) |
| Cash & equivalents | ¥45.0bn | at 2022-06-30 | Cons. | Cash and cash equivalents IFRS |
| Cash & equivalents | ¥42.3bn | at 2021-12-31 | Cons. | Cash and cash equivalents IFRS |
| Cash & equivalents | ¥31.9bn | at 2021-06-30 | Cons. | Cash and cash equivalents IFRS |
| Operating cash flow | ¥3.4bn | 2022-01-01 → 2022-06-30 | Cons. | Net cash provided by used in operating activities IFRS |
| Operating cash flow | ¥18.8bn | 2021-01-01 → 2021-12-31 | Cons. | Cash flows from used in operating activities IFRS (5-year summary) |
| Operating cash flow | ¥9.1bn | 2021-01-01 → 2021-06-30 | Cons. | Net cash provided by used in operating activities IFRS |
| Investing cash flow | −¥3.3bn | 2022-01-01 → 2022-06-30 | Cons. | Net cash provided by used in investing activities IFRS |
| Investing cash flow | −¥6.9bn | 2021-01-01 → 2021-12-31 | Cons. | Cash flows from used in investing activities IFRS (5-year summary) |
| Investing cash flow | −¥3.2bn | 2021-01-01 → 2021-06-30 | Cons. | Net cash provided by used in investing activities IFRS |
| Financing cash flow | −¥1.0bn | 2022-01-01 → 2022-06-30 | Cons. | Net cash provided by used in financing activities IFRS |
| Financing cash flow | ¥2.6bn | 2021-01-01 → 2021-12-31 | Cons. | Cash flows from used in financing activities IFRS (5-year summary) |
| Financing cash flow | −¥838m | 2021-01-01 → 2021-06-30 | Cons. | Net cash provided by used in financing activities IFRS |
| EPS (basic) | ¥158.62 | 2022-01-01 → 2022-06-30 | Cons. | Basic earnings loss per share IFRS |
| EPS (basic) | ¥92.76 | 2022-04-01 → 2022-06-30d | Cons. | Basic earnings loss per share IFRS |
| EPS (basic) | ¥318.35 | 2021-01-01 → 2021-12-31 | Cons. | Basic earnings loss per share IFRS (5-year summary) |
| EPS (basic) | ¥213 | 2021-01-01 → 2021-06-30 | Cons. | Basic earnings loss per share IFRS |
| EPS (basic) | ¥104.09 | 2021-04-01 → 2021-06-30d | Cons. | Basic earnings loss per share IFRS |
| EPS (diluted) | ¥317.16 | 2021-01-01 → 2021-12-31 | Cons. | Diluted earnings loss per share IFRS (5-year summary) |
| EPS (diluted) | ¥211.4 | 2021-01-01 → 2021-06-30 | Cons. | Diluted earnings loss per share IFRS |
| Equity ratio | 48.9% | at 2022-06-30 | Cons. | Ratio of owners equity to gross assets IFRS (5-year summary) |
| Equity ratio | 47.0% | at 2021-12-31 | Cons. | Ratio of owners equity to gross assets IFRS (5-year summary) |
| Equity ratio | 45.4% | at 2021-06-30 | Cons. | Ratio of owners equity to gross assets IFRS (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 28
| Segment | Item | Period | Value |
|---|---|---|---|
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2022-01-01 → 2022-06-30 | −¥446m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2022-04-01 → 2022-06-30 | −¥212m |
| Reconciling Itemsreconciling | segment profit | 2022-01-01 → 2022-06-30 | −¥400m |
| Reconciling Itemsreconciling | segment profit | 2022-04-01 → 2022-06-30 | −¥152m |
| jpcrp040300-q2r_E00703-000Devicesreportable segment | segment profit | 2022-01-01 → 2022-06-30 | ¥3.7bn |
| jpcrp040300-q2r_E00703-000Devicesreportable segment | segment profit | 2022-04-01 → 2022-06-30 | ¥2.3bn |
| jpcrp040300-q2r_E00703-000Industrial Materialsreportable segment | segment profit | 2022-01-01 → 2022-06-30 | ¥3.4bn |
| jpcrp040300-q2r_E00703-000Industrial Materialsreportable segment | segment profit | 2022-04-01 → 2022-06-30 | ¥1.9bn |
| jpcrp040300-q2r_E00703-000Medical Technologiesreportable segment | segment profit | 2022-01-01 → 2022-06-30 | ¥0 |
| jpcrp040300-q2r_E00703-000Medical Technologiesreportable segment | segment profit | 2022-04-01 → 2022-06-30 | −¥6m |
| —segment total | segment profit | 2022-01-01 → 2022-06-30 | ¥7.1bn |
| —segment total | segment profit | 2022-04-01 → 2022-06-30 | ¥4.1bn |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2022-01-01 → 2022-06-30 | ¥6.7bn |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2022-04-01 → 2022-06-30 | ¥3.9bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2021-01-01 → 2021-06-30 | −¥538m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2021-04-01 → 2021-06-30 | −¥205m |
| Reconciling Itemsreconciling | segment profit | 2021-01-01 → 2021-06-30 | −¥474m |
| Reconciling Itemsreconciling | segment profit | 2021-04-01 → 2021-06-30 | −¥774m |
| jpcrp040300-q2r_E00703-000Devicesreportable segment | segment profit | 2021-01-01 → 2021-06-30 | ¥8.6bn |
| jpcrp040300-q2r_E00703-000Devicesreportable segment | segment profit | 2021-04-01 → 2021-06-30 | ¥4.7bn |
| jpcrp040300-q2r_E00703-000Industrial Materialsreportable segment | segment profit | 2021-01-01 → 2021-06-30 | ¥2.8bn |
| jpcrp040300-q2r_E00703-000Industrial Materialsreportable segment | segment profit | 2021-04-01 → 2021-06-30 | ¥1.6bn |
| jpcrp040300-q2r_E00703-000Medical Technologiesreportable segment | segment profit | 2021-01-01 → 2021-06-30 | ¥487m |
| jpcrp040300-q2r_E00703-000Medical Technologiesreportable segment | segment profit | 2021-04-01 → 2021-06-30 | ¥209m |
| —segment total | segment profit | 2021-01-01 → 2021-06-30 | ¥11.9bn |
| —segment total | segment profit | 2021-04-01 → 2021-06-30 | ¥6.5bn |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2021-01-01 → 2021-06-30 | ¥11.3bn |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2021-04-01 → 2021-06-30 | ¥6.3bn |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 942
| Item | Context | Value | Unit |
|---|---|---|---|
| Finance income IFRS | CurrentYTDDuration_ReconcilingItemsMember | - | JPY |
| Finance income IFRS | CurrentYTDDuration | 3694000000 | JPY |
| Finance costs IFRS | CurrentYTDDuration_jpcrp040300-q2r_E00703-000IndustrialMaterialsReportableSegmentMember | - | JPY |
| Finance costs IFRS | CurrentYTDDuration_jpcrp040300-q2r_E00703-000DevicesReportableSegmentMember | - | JPY |
| Finance costs IFRS | CurrentYTDDuration_jpcrp040300-q2r_E00703-000MedicalTechnologiesReportableSegmentMember | - | JPY |
| Finance costs IFRS | CurrentYTDDuration_ReportableSegmentsMember | - | JPY |
| Finance costs IFRS | CurrentYTDDuration_OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember | - | JPY |
| Finance costs IFRS | CurrentYTDDuration_TotalOfReportableSegmentsAndOthersMember | - | JPY |
| Finance costs IFRS | CurrentYTDDuration_ReconcilingItemsMember | - | JPY |
| Finance costs IFRS | CurrentYTDDuration | 413000000 | JPY |
| Profit loss before tax IFRS | CurrentYTDDuration_jpcrp040300-q2r_E00703-000IndustrialMaterialsReportableSegmentMember | - | JPY |
| Profit loss before tax IFRS | CurrentYTDDuration_jpcrp040300-q2r_E00703-000DevicesReportableSegmentMember | - | JPY |
| Profit loss before tax IFRS | CurrentYTDDuration_jpcrp040300-q2r_E00703-000MedicalTechnologiesReportableSegmentMember | - | JPY |
| Profit loss before tax IFRS | CurrentYTDDuration_ReportableSegmentsMember | - | JPY |
| Profit loss before tax IFRS | CurrentYTDDuration_OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember | - | JPY |
| Profit loss before tax IFRS | CurrentYTDDuration_TotalOfReportableSegmentsAndOthersMember | - | JPY |
| Profit loss before tax IFRS | CurrentYTDDuration_ReconcilingItemsMember | - | JPY |
| Profit loss before tax IFRS | CurrentYTDDuration | 9549000000 | JPY |
| Sales to external customers IFRS | Prior1QuarterDuration_jpcrp040300-q2r_E00703-000IndustrialMaterialsReportableSegmentMember | 15520000000 | JPY |
| Sales to external customers IFRS | Prior1QuarterDuration_jpcrp040300-q2r_E00703-000DevicesReportableSegmentMember | 27001000000 | JPY |
| Sales to external customers IFRS | Prior1QuarterDuration_jpcrp040300-q2r_E00703-000MedicalTechnologiesReportableSegmentMember | 6098000000 | JPY |
| Sales to external customers IFRS | Prior1QuarterDuration_ReportableSegmentsMember | 48620000000 | JPY |
| Sales to external customers IFRS | Prior1QuarterDuration_OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember | 1824000000 | JPY |
| Sales to external customers IFRS | Prior1QuarterDuration_TotalOfReportableSegmentsAndOthersMember | 50444000000 | JPY |
| Sales to external customers IFRS | Prior1QuarterDuration_ReconcilingItemsMember | - | JPY |
| Sales to external customers IFRS | Prior1QuarterDuration | 50444000000 | JPY |
| Intersegment sales IFRS | Prior1QuarterDuration_jpcrp040300-q2r_E00703-000IndustrialMaterialsReportableSegmentMember | 246000000 | JPY |
| Intersegment sales IFRS | Prior1QuarterDuration_jpcrp040300-q2r_E00703-000DevicesReportableSegmentMember | -0 | JPY |
| Intersegment sales IFRS | Prior1QuarterDuration_jpcrp040300-q2r_E00703-000MedicalTechnologiesReportableSegmentMember | - | JPY |
| Intersegment sales IFRS | Prior1QuarterDuration_ReportableSegmentsMember | 245000000 | JPY |
| Intersegment sales IFRS | Prior1QuarterDuration_OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember | 333000000 | JPY |
| Intersegment sales IFRS | Prior1QuarterDuration_TotalOfReportableSegmentsAndOthersMember | 579000000 | JPY |
| Intersegment sales IFRS | Prior1QuarterDuration_ReconcilingItemsMember | -579000000 | JPY |
| Intersegment sales IFRS | Prior1QuarterDuration | - | JPY |
| Net sales IFRS | Prior1QuarterDuration_jpcrp040300-q2r_E00703-000IndustrialMaterialsReportableSegmentMember | 15767000000 | JPY |
| Net sales IFRS | Prior1QuarterDuration_jpcrp040300-q2r_E00703-000DevicesReportableSegmentMember | 27000000000 | JPY |
| Net sales IFRS | Prior1QuarterDuration_jpcrp040300-q2r_E00703-000MedicalTechnologiesReportableSegmentMember | 6098000000 | JPY |
| Net sales IFRS | Prior1QuarterDuration_ReportableSegmentsMember | 48866000000 | JPY |
| Net sales IFRS | Prior1QuarterDuration_OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember | 2157000000 | JPY |
| Net sales IFRS | Prior1QuarterDuration_TotalOfReportableSegmentsAndOthersMember | 51023000000 | JPY |
| Net sales IFRS | Prior1QuarterDuration_ReconcilingItemsMember | -579000000 | JPY |
| Net sales IFRS | Prior1QuarterDuration | 50444000000 | JPY |
| Operating profit loss IFRS | Prior1QuarterDuration_jpcrp040300-q2r_E00703-000IndustrialMaterialsReportableSegmentMember | 1575000000 | JPY |
| Operating profit loss IFRS | Prior1QuarterDuration_jpcrp040300-q2r_E00703-000DevicesReportableSegmentMember | 4737000000 | JPY |
| Operating profit loss IFRS | Prior1QuarterDuration_jpcrp040300-q2r_E00703-000MedicalTechnologiesReportableSegmentMember | 209000000 | JPY |
| Operating profit loss IFRS | Prior1QuarterDuration_ReportableSegmentsMember | 6522000000 | JPY |
| Operating profit loss IFRS | Prior1QuarterDuration_OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember | -205000000 | JPY |
| Operating profit loss IFRS | Prior1QuarterDuration_TotalOfReportableSegmentsAndOthersMember | 6316000000 | JPY |
| Operating profit loss IFRS | Prior1QuarterDuration_ReconcilingItemsMember | -774000000 | JPY |
| Operating profit loss IFRS | Prior1QuarterDuration | 5542000000 | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 12 of 12 passed
| balance sheet identity | pass |
| balance sheet identity | pass rounding |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |